We are live on ! Find out more
BCM

Brooktree Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 0.5%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
-0.5%
3 Year Est. Return
+57.3%
5 Year Est. Return
+44.35%
10 Year Est. Return
AUM
$153M
AUM Growth
+$19.7M
Cap. Flow
+$8.76M
Cap. Flow %
5.73%
Top 10 Hldgs %
79.74%
Holding
43
New
19
Increased
17
Reduced
5
Closed
2

Top Sells

Rank Stock Value
1
ANGI icon
Angi Inc
ANGI
+$1.95M
2
IBKR icon
Interactive Brokers
IBKR
+$214K
3
AAPL icon
Apple
AAPL
+$198K
4
LLY icon
Eli Lilly
LLY
+$169K
5
MSFT icon
Microsoft
MSFT
+$21.7K

Sector Composition

Rank Sector Weight
1 Technology 45.77%
2 Financials 32.32%
3 Healthcare 10.26%
4 Communication Services 6.75%
5 Industrials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBKR icon
1
Interactive Brokers
IBKR
$38.4B
$27.8M 18.18%
501,839
-4,501
-0.9% -$214K
PAR icon
2
PAR Technology
PAR
$716M
$22.7M 14.87%
327,762
+155
+0% +$9.68K
RMNI icon
3
Rimini Street
RMNI
$457M
$14.7M 9.62%
3,902,223
+15,770
+0.4% +$52.7K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.1T
$10.2M 6.68%
21,032
+2,084
+11% +$1.06M
PPLI
5
People Inc
PPLI
$3.12B
$9.21M 6.02%
+246,677
New +$8.91M
BFH icon
6
Bread Financial
BFH
$4.32B
$8.92M 5.83%
156,082
+2,189
+1% +$110K
THRY icon
7
Thryv Holdings
THRY
$184M
$8.7M 5.69%
715,630
+15,595
+2% +$201K
FISV
8
Fiserv Inc
FISV
$29.7B
$7.78M 5.09%
45,149
+701
+2% +$127K
QCOM icon
9
Qualcomm
QCOM
$164B
$7.46M 4.88%
46,866
+2,863
+7% +$421K
JNJ icon
10
Johnson & Johnson
JNJ
$640B
$4.41M 2.88%
28,849
+2,897
+11% +$445K
EXTR icon
11
Extreme Networks
EXTR
$3.8B
$3.95M 2.58%
220,042
+10,995
+5% +$162K
PFE icon
12
Pfizer
PFE
$143B
$2.94M 1.92%
121,355
+3,184
+3% +$74.3K
DXCM icon
13
DexCom
DXCM
$29B
$2.55M 1.67%
29,245
+13,713
+88% +$1.07M
MSFT icon
14
Microsoft
MSFT
$2.9T
$2.45M 1.6%
4,927
-50
-1% -$21.7K
GD icon
15
General Dynamics
GD
$103B
$2.16M 1.41%
7,416
+1,305
+21% +$359K
LLY icon
16
Eli Lilly
LLY
$1.08T
$1.75M 1.14%
2,246
-218
-9% -$169K
RKT icon
17
Rocket Companies
RKT
$38.8B
$1.65M 1.08%
116,565
+4,492
+4% +$58.3K
DXC icon
18
DXC Technology
DXC
$1.91B
$1.53M 1%
99,954
+2,683
+3% +$41.3K
IYW icon
19
iShares US Technology ETF
IYW
$22.6B
$1.17M 0.76%
+6,746
New +$1.02M
XOM icon
20
ExxonMobil
XOM
$650B
$1.09M 0.71%
+10,076
New +$1.08M
WST icon
21
West Pharmaceutical
WST
$23.7B
$1.08M 0.7%
4,925
+185
+4% +$39.5K
SYK icon
22
Stryker
SYK
$135B
$1.07M 0.7%
+2,693
New +$1.01M
ABBV icon
23
AbbVie
ABBV
$465B
$920K 0.6%
4,958
+3,900
+369% +$725K
ABT icon
24
Abbott
ABT
$187B
$694K 0.45%
+5,100
New +$673K
MCD icon
25
McDonald's
MCD
$193B
$671K 0.44%
+2,296
New +$708K

Similar funds

Brooktree Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Brooktree Capital Management held 43 positions worth $153M, up 15% from $133M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Brooktree Capital Management deployed $8.76M of net new capital in Q2 2025, opening 19 new positions and adding to 17 existing holdings. Its largest new stake was People Inc: 246,677 shares worth $9.21M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 50% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Interactive Brokers, an estimated $214K trimmed.

  • Brooktree Capital Management's largest Q2 2025 buy was People Inc: 246,677 shares worth $9.21M.
  • Brooktree Capital Management added most to DexCom in Q2 2025, an estimated $1.07M increase.
  • Brooktree Capital Management's biggest Q2 2025 reduction was Interactive Brokers, cutting an estimated $214K.
  • Brooktree Capital Management fully exited Angi Inc in Q2 2025, selling an estimated $1.95M.
  • Brooktree Capital Management's ten largest holdings make up 80% of its $153M portfolio in Q2 2025.
  • Brooktree Capital Management opened 19 new positions and closed 2 in Q2 2025.
  • Brooktree Capital Management's portfolio value rose 15% quarter-over-quarter to $153M.

Based on Brooktree Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.